This is a U.S. news story, published by KFF Health News, that relates primarily to Novo Nordisk news.
For more U.S. news, you can click here:
more U.S. newsFor more Novo Nordisk news, you can click here:
more Novo Nordisk newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from KFF Health News, you can click here:
more news from KFF Health NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diet drugs news, Olympia Pharmaceuticals news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Pharmacist Mark MikhaelKFF Health News
•72% Informative
Compounding pharmacies are provisioning up to 2 million American patients with semaglutide and tirzepatide.
FDA allows and even encourages compounding pharmacies to produce and sell copycats when a drug is in short supply.
Compounders say they uphold standards of purity, sterility, consistency similar to those practiced in the commercial drug industry.
Compounding pharmacies may account for up to 30% of semaglutide sold in the U.S. , compounders say.
Novo Nordisk says it's investing $4.1 billion in new production lines at its North Carolina site.
Compounders say the companies should increase production if they’re worried about competition.
Compounding semaglutide is a helpful sideline for pharmacists like him, Welch said.
Compounding forms of the drug are not FDA -approved, but those who make, prescribe, or use them also should have “an increased level of responsibility or awareness,” FDA spokesperson Amanda Hils said.
VR Score
67
Informative language
67
Neutral language
62
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
5
Affiliate links
no affiliate links